BrainZ Instruments to Present at Medtech Insight's ``Investment In Innovation'' Conference.Business Editors/Health/Medical Writers Medtech Insight 2004 In3 San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden Conference SAN FRANCISCO--(BUSINESS WIRE)--June 7, 2004 BrainZ Instruments will be presenting on June 8 at Medtech Insight's Prestigious "Investment In Innovation" Event, taking place June 8-9, 2004 at the Palace Hotel in San Francisco, California “San Francisco” redirects here. For other uses, see San Francisco (disambiguation). The City and County of San Francisco (EN IPA: [sænfrənˈsɪskoʊ] BrainZ Instruments is a New Zealand-based medical platform technology company specializing in bedside brain monitoring. BrainZ's currently commercialized product, the BRM BRM biologic response modifier. BRM Biological response modifier, see there 2 monitor, is a non-invasive device that uses sophisticated digital signal processing See DSP. Digital Signal Processing - (DSP) Computer manipulation of analog signals (commonly sound or image) which have been converted to digital form (sampled). technology to offer real-time quantitative data capable of translating into clinically useful diagnostic information regarding brain injury and seizure activity. The monitor is now in use in over 80% of Neonatal Intensive Care Units in Australia and New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. and is both FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and CE mark approved. The opportunity for bedside brain monitoring is largely unmet, but the fledgling industry is showing increasing clinical awareness and potential for strong growth. Estimates of the global market potential of the bedside brain monitoring industry exceed $500 million. Interest in real-time brain monitoring has increased greatly in recent times as clinicians realise the brain, our most important organ, is usually unmonitored in the intensive medical settings. BrainZ Instruments has an exciting research and development programme designed to expand the technology into Paediatric Adj. 1. paediatric - of or relating to the medical care of children; "pediatric dentist" pediatric and Adult Intensive Care markets as well as defined markets in cardiac surgery Cardiac surgery is surgery on the heart and/or great vessels performed by a cardiac surgeon. Frequently, it is done to treat complications of ischemic heart disease (for example, coronary artery bypass grafting), correct congenital heart disease, or treat valvular heart disease , post-operative units and the ER. The company has support from international opinion leaders and has accumulated the largest set of outcome data for any bedside brain monitor. The technology behind BrainZ Instruments stems from the University of Auckland's medical research facility, the Liggins Institute, an internationally respected centre of medical research. This technology is protected through a robust intellectual property portfolio. The BrainZ company is supported by experienced management, led by their Chief Executive Dr. Justin Vaughan Justin Thomas Caldwell Vaughan (b. 30 August, 1967) in Hereford, England. He played 6 Tests and 18 one-day internationals and he is a doctor of medicine and a keen all-rounder. . The current key priorities for BrainZ are to commercialize the innovative BrainZ technology into the major global markets, including the USA and Europe. About Medtech Insight Medtech Insight's "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conferences are considered the premier forum for senior executives in the medical technology and investment community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership. In addition to conferences, Medtech Insight publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry, analyses of medtech markets through its Reports group, and offers custom consulting and market research. To register for the San Francisco conference or for more information on Medtech Insight, please call Scott Pantel at 949-219-0150 or 888-290-2225 toll-free in the U.S., e-mail in3@medtechinsight.com, or visit http://www.medtechinsight.com/in3-11.html. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion